Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)
Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)
Active, not recruiting · NCT06852768 · Registry updated 2026-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD) | oGHVD | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-08 | NCT06852768 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regenerative Ocular Immunobiologics LLC | 2 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beach Eye Medical Group | Huntington Beach | United States | 1 |
| Beverly Hills Institute of Ophthalmology | Beverly Hills | United States | 3 |
| BostonSight | Boston | United States | 2 |
| Eyewell, LLC. | Boston | United States | 2 |
| Glenn Eye Center | Lexington | United States | 1 |
| Regenerative Ocular Immunobiologics, LLC. | Palm Harbor | United States | 2 |